DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER
Rizk, A., ElShafei, M., Abdelsattar, M., Hegazy, H., Mohamed, Y. (2024). DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER. EKB Journal Management System, 6(4), 34-35. doi: 10.21608/alexpo.2024.329044.1973
Adel Mohamed Rizk; Mohamed Mahmoud ElShafei; Mohamed Ali Abdelsattar; Hanady Mahmoud Hegazy; Youssef Amr Abdelaziz Mohamed. "DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER". EKB Journal Management System, 6, 4, 2024, 34-35. doi: 10.21608/alexpo.2024.329044.1973
Rizk, A., ElShafei, M., Abdelsattar, M., Hegazy, H., Mohamed, Y. (2024). 'DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER', EKB Journal Management System, 6(4), pp. 34-35. doi: 10.21608/alexpo.2024.329044.1973
Rizk, A., ElShafei, M., Abdelsattar, M., Hegazy, H., Mohamed, Y. DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER. EKB Journal Management System, 2024; 6(4): 34-35. doi: 10.21608/alexpo.2024.329044.1973

DIAGNOSTIC VALUE OF TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY AFTER PSMA/PET CT IN RESIDUAL/RECURRENT PROSTATE CANCER

ALEXMED ePosters
Article 1, Volume 6, Issue 4, September 2024, Pages 34-35
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.329044.1973
Authors
Adel Mohamed Rizk1; Mohamed Mahmoud ElShafei2; Mohamed Ali Abdelsattar3; Hanady Mahmoud Hegazy4; Youssef Amr Abdelaziz Mohamed* 5
1Department of radiodiagnosis, Faculty of Medicine University of Alexandria.
2Department of Radiodiagnosis and Intervention, Faculty of Medicine, Alexandria University
3Department of Genitourinary surgery, Faculty of Medicine, University of Alexandria
4Department of Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria
5Department of Radiodiagnosis and Intervention, Faculty of Medicine, University of Alexandria
Abstract
Prostate cancer represents a significant global health concern, ranking as the second most prevalent male malignancy after lung cancer. In the past two decades, there has been a notable shift in focus toward the diagnostic significance of systematic screening and early detection programs, including serum prostate-specific antigen (PSA) testing has led to a marked reduction in the incidence of advanced-stage progression in prostate cancer (PCa) at the time of diagnosis. The Gleason grading system of PCa assigns a score based on how closely the prostate tissue resembles normal glandular structures under a microscope. As for imaging, while transrectal ultrasound (TRUS)-guided biopsy and MRI have proven useful in prostate cancer, Prostate specific membrane antigen (PSMA) positron emission tomography (PET) Computed tomography (CT), a.k.a PSMA-PET CT is currently on the rise regarding localization of metabolically active prostatic tissue to guide TRUS guided sampling procedures.
Aim:
The aim of this work was to assess the diagnostic value of TRUS guided prostate biopsy compared to PSMA PET/CT in detection of prostate cancer in residual/recurrent disease.
Keywords
PSMA/PET; PROSTATE; BIOPSY
Supplementary Files
Statistics
Article View: 4